login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SCHRODINGER INC (SDGR) Stock News
NASDAQ:SDGR -
US80810D1037
-
Common Stock
19.16
USD
+0.19 (+1%)
Last: 9/5/2025, 11:22:03 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SDGR Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Schrödinger
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
18 days ago - By: Benzinga
What 4 Analyst Ratings Have To Say About Schrodinger
21 days ago - By: Schrödinger
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
21 days ago - By: Benzinga
- Mentions:
CSCO
AIT
BJ
TGT
This Cisco Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
22 days ago - By: Schrödinger
Schrödinger Announces Discontinuation of SGR-2921 Program
a month ago - By: Zacks Investment Research
- Mentions:
VEEV
Schrodinger, Inc. (SDGR) Reports Q2 Loss, Beats Revenue Estimates
a month ago - By: The Motley Fool
- Mentions:
NVS
Schrödinger (SDGR) Q2 2025 Earnings Transcript
a month ago - By: Schrödinger
Schrödinger Reports Second Quarter 2025 Financial Results
a month ago - By: Zacks Investment Research
- Mentions:
CLOV
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
a month ago - By: Zacks Investment Research
- Mentions:
VEEV
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
a month ago - By: Schrödinger
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
2 months ago - By: Schrödinger
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Schrödinger
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target
2 months ago - By: Zacks Investment Research
- Mentions:
RLAY
RXRX
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
2 months ago - By: Zacks Investment Research
- Mentions:
RLAY
RXRX
Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith?
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: Yahoo Finance
Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505
2 months ago - By: Yahoo Finance
- Mentions:
PNC
FDX
AMZN
UPS
...
Meta upgraded, PNC Financial downgraded: Wall Street's top analyst calls
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: Schrödinger
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Schrödinger
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Schrödinger
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
3 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR
Please enable JavaScript to continue using this application.